Aerus ActivePure® Technology Air Purifier reduces SARS-CoV-2 on Surfaces in Lab Results by >99%
Aerus’ award-winning ActivePure® Technology is scientifically proven to destroy microscopic pathogens and contaminants on surfaces and in the air and is available in over 70 Aerus products, including the Aerus Medical Guardian cleared by the FDA as a Class II Medical Device 510(k). The Aerus Hydroxyl Blaster with ActivePure® Technology is an affordable, mobile, plugand-purify air purifier that works on interior aerosolized pathogens and surface contaminants. Controlled, independent laboratory studies have established the efficacy of ActivePure® Technology in Aerus products including:
93% surface kill in three hours of live SARS-CoV-2, even when covered by a protective biofilm, with the Aerus Hydroxyl Blaster with ActivePure® Technology
98% surface kill in six hours of live SARS-CoV-2, even when covered by a protective biofilm, with the Aerus Hydroxyl Blaster with ActivePure® Technology
99.999% kill rate of airborne RNA viruses in just 30 minutes with the Aerus Medical Guardian with ActivePure® Technology, an FDA 510(k) Cleared Class II Medical Device
99.9999% kill rate of airborne RNA viruses in 60 minutes with the Aerus Medical Guardian with ActivePure® Technology
“We have a technology demonstrated in independent lab studies to kill COVID-19 indoors and gets the world back to work, back to school and back to life in a safer manner. Our unit works in real time to destroy 99.98% of new COVID-19 viruses reintroduced to the space, after just seven hours of installation,” said Joe Urso, chief executive officer of Aerus. “The efficacy of our data is consistent with our other previously reported RNA and DNA virus test data and confirms that ActivePure® Technology used in our surface and air purification systems is the fastest-acting continuous solution available. We are beyond pleased to announce these COVID-19 disinfection results with our ActivePure® Technology solutions.”